{"items": "66", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying", "url": "https://www.zacks.com/stock/news/2387313/3-under-10-drug-stocks-wall-street-analysts-recommend-buying", "time_published": "20241224T124700", "authors": ["Sundeep Ganoria"], "summary": "We present three small biotech stocks, which according to Wall Street analysts, have upside potential for 2025.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/34/973.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.098065, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALLO", "relevance_score": "0.194632", "ticker_sentiment_score": "0.040849", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.04912", "ticker_sentiment_score": "0.041061", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNDA", "relevance_score": "0.194632", "ticker_sentiment_score": "0.076227", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.241924", "ticker_sentiment_score": "0.116636", "ticker_sentiment_label": "Neutral"}]}, {"title": "Akari Therapeutics Announces Key Leadership Appointments - Akari Therapeutics  ( NASDAQ:AKTX ) ", "url": "https://www.benzinga.com/pressreleases/24/12/g42553004/akari-therapeutics-announces-key-leadership-appointments", "time_published": "20241218T135129", "authors": ["Globe Newswire"], "summary": "Samir R. Patel, M.D., appointed as Chief Executive Officer Abizer Gaslightwala appointed to Board of Directors BOSTON and LONDON, Dec. 18, 2024 ( GLOBE NEWSWIRE ) -- Akari Therapeutics, Plc AKTX today announced the appointment of Samir R. Patel, M.D., as Chief Executive Officer, effective ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/110aebf9-2683-41c9-ba9d-bf06f7e42054/image1.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.165645, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AKTX", "relevance_score": "0.094112", "ticker_sentiment_score": "0.05996", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURN", "relevance_score": "0.023579", "ticker_sentiment_score": "0.034377", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAZZ", "relevance_score": "0.047138", "ticker_sentiment_score": "0.07564", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.023579", "ticker_sentiment_score": "0.116935", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.023579", "ticker_sentiment_score": "0.030003", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.094112", "ticker_sentiment_score": "0.094619", "ticker_sentiment_label": "Neutral"}]}, {"title": "Akari Therapeutics Announces Key Leadership Appointments", "url": "https://www.globenewswire.com/news-release/2024/12/18/2999072/0/en/Akari-Therapeutics-Announces-Key-Leadership-Appointments.html", "time_published": "20241218T135100", "authors": ["Akari Therapeutics Plc"], "summary": "Samir R. Patel, M.D., appointed as Chief Executive Officer ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/110aebf9-2683-41c9-ba9d-bf06f7e42054/image1.png", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.16341, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AKTX", "relevance_score": "0.097754", "ticker_sentiment_score": "0.062871", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURN", "relevance_score": "0.024496", "ticker_sentiment_score": "0.034558", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAZZ", "relevance_score": "0.048969", "ticker_sentiment_score": "0.075796", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.024496", "ticker_sentiment_score": "0.119418", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.024496", "ticker_sentiment_score": "0.031086", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.097754", "ticker_sentiment_score": "0.097682", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2024/12/05/2992267/0/en/Rezolute-Reports-Inducement-Award-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20241205T130000", "authors": ["Inc.", "Rezolute"], "summary": "REDWOOD CITY, Calif., Dec. 05, 2024 ( GLOBE NEWSWIRE ) -- Rezolute, Inc. ( Nasdaq: RZLT ) ( \"Rezolute\" or the \"Company\" ) , a late-stage biopharmaceutical company dedicated to developing transformative therapies for rare diseases with serious unmet needs, today announced that its compensation ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.714479"}], "overall_sentiment_score": 0.22371, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.465599", "ticker_sentiment_score": "0.283489", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "RZLT Stock Rises on FDA's Orphan Designation for Rare Disease Drug", "url": "https://www.zacks.com/stock/news/2378939/rzlt-stock-rises-on-fdas-orphan-designation-for-rare-disease-drug", "time_published": "20241204T145500", "authors": ["Zacks Equity Research"], "summary": "The FDA bestows an Orphan Drug status to Rezolute's ersodetug for treating hypoglycemia due to tumor hyperinsulinism. Shares rise.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.045853, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMCR", "relevance_score": "0.220141", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.290607", "ticker_sentiment_score": "0.041367", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.358669", "ticker_sentiment_score": "-0.209591", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CSTL", "relevance_score": "0.290607", "ticker_sentiment_score": "0.100622", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute to Participate in Upcoming Investor Conferences - Rezolute  ( NASDAQ:RZLT ) ", "url": "https://www.benzinga.com/pressreleases/24/11/g41742692/rezolute-to-participate-in-upcoming-investor-conferences", "time_published": "20241105T130000", "authors": ["Globe Newswire"], "summary": "REDWOOD CITY, Calif., Nov. 05, 2024 ( GLOBE NEWSWIRE ) -- Rezolute, Inc. RZLT ( \"Rezolute\" or the \"Company\" ) , a late-stage biopharmaceutical company dedicated to developing transformative therapies for rare diseases with serious unmet needs, today announced that management will participate in ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.267992, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.84035", "ticker_sentiment_score": "0.372948", "ticker_sentiment_label": "Bullish"}]}, {"title": "Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update", "url": "https://www.globenewswire.com/news-release/2024/09/19/2949414/0/en/Rezolute-Reports-Fourth-Quarter-and-Full-Year-Fiscal-2024-Financial-Results-and-Provides-Business-Update.html", "time_published": "20240919T200500", "authors": ["Rezolute", "Inc."], "summary": "FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI. Phase 3 sunRIZE study to proceed in the U.S.", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.167681, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.308891", "ticker_sentiment_score": "0.209113", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "RZLT Stock Up as FDA Lifts Clinical Holds on Rare Disease Study", "url": "https://www.zacks.com/stock/news/2334074/rzlt-stock-up-as-fda-lifts-clinical-holds-on-rare-disease-study", "time_published": "20240910T144400", "authors": ["Zacks Equity Research"], "summary": "The FDA removes the partial clinical holds on Rezolute's phase III study evaluating RZ358 for treating congenital hyperinsulinism.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.990678"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.188912, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KRYS", "relevance_score": "0.256314", "ticker_sentiment_score": "0.221645", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.193723", "ticker_sentiment_score": "0.156341", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RZLT", "relevance_score": "0.432818", "ticker_sentiment_score": "0.158042", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FULC", "relevance_score": "0.256314", "ticker_sentiment_score": "0.096961", "ticker_sentiment_label": "Neutral"}]}, {"title": "FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment Why Is Rezolute Stock Jumping Today? - Rezolute  ( NASDAQ:RZLT ) ", "url": "https://www.benzinga.com/general/biotech/24/09/40775411/fda-gives-green-signal-to-rezolutes-genetic-disorder-treatment", "time_published": "20240909T144159", "authors": ["Vandana Singh"], "summary": "Monday, the FDA removed partial clinical holds on Rezolute, Inc.'s RZLT RZ358 ( ersodetug ) , a potential treatment for hypoglycemia ( low blood sugar ) caused by congenital hyperinsulinism ( HI ) .", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/09/09/Health-And-Longevity.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.088681, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.495015", "ticker_sentiment_score": "0.031098", "ticker_sentiment_label": "Neutral"}]}, {"title": "FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study", "url": "https://www.globenewswire.com/news-release/2024/09/09/2942720/0/en/FDA-Lifts-Partial-Clinical-Holds-on-RZ358-for-the-Treatment-of-Congenital-Hyperinsulinism-and-Authorizes-U-S-Inclusion-in-Ongoing-Phase-3-Study.html", "time_published": "20240909T113000", "authors": ["Rezolute", "Inc."], "summary": "Commencing study startup activities in the U.S. participant enrollment anticipated in early 2025 Commencing study startup activities in the U.S. participant enrollment anticipated in early ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.093793, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.213988", "ticker_sentiment_score": "0.100923", "ticker_sentiment_label": "Neutral"}]}, {"title": "XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities", "url": "https://www.globenewswire.com/news-release/2024/08/13/2929086/7281/en/XOMA-Royalty-Reports-Second-Quarter-2024-Financial-Results-and-Highlights-Recent-Activities.html", "time_published": "20240813T113000", "authors": ["XOMA Corporation"], "summary": "Cash receipts totaled $22.6 million in 2Q24, inclusive of royalty income and milestones from Day One Pharmaceuticals and ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/46cbb269-1ae4-4441-a46a-d782ffb436dc", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.998947"}, {"topic": "Earnings", "relevance_score": "0.839681"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.160867, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.051718", "ticker_sentiment_score": "0.110493", "ticker_sentiment_label": "Neutral"}, {"ticker": "DARE", "relevance_score": "0.025873", "ticker_sentiment_score": "0.169309", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism - Rezolute  ( NASDAQ:RZLT ) ", "url": "https://www.benzinga.com/pressreleases/24/08/g40157205/rezolute-announces-fda-clearance-of-ind-application-for-phase-3-registrational-study-of-rz358-for-", "time_published": "20240805T113000", "authors": ["Globe Newswire"], "summary": "Second rare disease program with RZ358 in Phase 3 development Follows successful treatment of multiple patients with tumor hyperinsulinism under the Company's Expanded Access Program REDWOOD CITY, Calif., Aug. 05, 2024 ( GLOBE NEWSWIRE ) -- Rezolute, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.451494"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.090284, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.208464", "ticker_sentiment_score": "0.096124", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism", "url": "https://www.globenewswire.com/news-release/2024/08/05/2924196/0/en/Rezolute-Announces-FDA-Clearance-of-IND-Application-for-Phase-3-Registrational-Study-of-RZ358-for-Treatment-of-Hypoglycemia-Due-to-Tumor-Hyperinsulinism.html", "time_published": "20240805T113000", "authors": ["Inc.", "Rezolute"], "summary": "Second rare disease program with RZ358 in Phase 3 development ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.451494"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.078518, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.182506", "ticker_sentiment_score": "0.090158", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute Announces Exercise of Underwriters' Option to Purchase Additional Shares and Concurrent Private Placement", "url": "https://www.globenewswire.com/news-release/2024/06/27/2905128/0/en/Rezolute-Announces-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares-and-Concurrent-Private-Placement.html", "time_published": "20240627T120000", "authors": ["Rezolute", "Inc."], "summary": "Additional $6.7M in funding resulting in approximately $67M in gross proceeds Additional $6.7M in funding resulting in approximately $67M in gross proceeds ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.9545"}, {"topic": "Financial Markets", "relevance_score": "0.99246"}], "overall_sentiment_score": 0.149987, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.20279", "ticker_sentiment_score": "0.186719", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Adobe  ( NASDAQ:ADBE ) ", "url": "https://www.benzinga.com/news/24/06/39331171/why-adobe-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket", "time_published": "20240614T121925", "authors": ["Avi Kapoor"], "summary": "Shares of Adobe Inc. ADBE rose sharply in today's pre-market trading following better-than-expected second-quarter earnings and strong guidance. Adobe reported second-quarter revenue of $5.31 billion, beating the consensus estimate of $5.292 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/14/movers-image_7.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.142516, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CERO", "relevance_score": "0.137278", "ticker_sentiment_score": "0.089192", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXL", "relevance_score": "0.204647", "ticker_sentiment_score": "0.108429", "ticker_sentiment_label": "Neutral"}, {"ticker": "GANX", "relevance_score": "0.137278", "ticker_sentiment_score": "-0.043385", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.204647", "ticker_sentiment_score": "0.065894", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSM", "relevance_score": "0.137278", "ticker_sentiment_score": "-0.109383", "ticker_sentiment_label": "Neutral"}, {"ticker": "CJET", "relevance_score": "0.137278", "ticker_sentiment_score": "0.164482", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VXRT", "relevance_score": "0.137278", "ticker_sentiment_score": "0.194883", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KAVL", "relevance_score": "0.137278", "ticker_sentiment_score": "-0.057169", "ticker_sentiment_label": "Neutral"}, {"ticker": "OST", "relevance_score": "0.137278", "ticker_sentiment_score": "-0.227691", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PRFX", "relevance_score": "0.137278", "ticker_sentiment_score": "0.222315", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NCI", "relevance_score": "0.137278", "ticker_sentiment_score": "-0.165254", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RH", "relevance_score": "0.137278", "ticker_sentiment_score": "-0.048788", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.137278", "ticker_sentiment_score": "-0.032681", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADBE", "relevance_score": "0.270523", "ticker_sentiment_score": "0.304762", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RIOT", "relevance_score": "0.137278", "ticker_sentiment_score": "0.050109", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAPT", "relevance_score": "0.137278", "ticker_sentiment_score": "0.336342", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KITT", "relevance_score": "0.137278", "ticker_sentiment_score": "0.202177", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday - Adobe  ( NASDAQ:ADBE ) ", "url": "https://www.benzinga.com/news/earnings/24/06/39328646/adobe-avidity-biosciences-and-3-stocks-to-watch-heading-into-friday", "time_published": "20240614T100809", "authors": ["Avi Kapoor"], "summary": "With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows: Adobe Inc. ADBE posted upbeat results for its second quarter and also issued a strong forecast.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/14/Adobe.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.314174, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ADBE", "relevance_score": "0.495015", "ticker_sentiment_score": "0.531366", "ticker_sentiment_label": "Bullish"}, {"ticker": "RFIL", "relevance_score": "0.382925", "ticker_sentiment_score": "0.429302", "ticker_sentiment_label": "Bullish"}, {"ticker": "POWW", "relevance_score": "0.382925", "ticker_sentiment_score": "0.20246", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RNA", "relevance_score": "0.382925", "ticker_sentiment_score": "0.303359", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RZLT", "relevance_score": "0.382925", "ticker_sentiment_score": "0.222774", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "RH Posts Mixed Q1 Results, Joins MSC Industrial Direct And Other Big Stocks Moving Lower In Friday's Pre-Market Session - RH  ( NYSE:RH ) ", "url": "https://www.benzinga.com/news/24/06/39328375/rh-posts-mixed-q1-results-joins-msc-industrial-direct-and-other-big-stocks-moving-lower-in-fridays-p", "time_published": "20240614T095026", "authors": ["Avi Kapoor"], "summary": "U.S. stock futures were lower this morning, with the Dow futures falling around 250 points on Friday. Shares of RH RH fell sharply in today's pre-market trading after the company reported mixed first-quarter financial results.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/14/xrdDAFekDI-j282-j1745615867-t23032908.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.99977"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": -0.034699, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.238133", "ticker_sentiment_score": "-0.118855", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLAY", "relevance_score": "0.238133", "ticker_sentiment_score": "0.083191", "ticker_sentiment_label": "Neutral"}, {"ticker": "DV", "relevance_score": "0.120431", "ticker_sentiment_score": "0.082854", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSM", "relevance_score": "0.238133", "ticker_sentiment_score": "-0.161104", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RH", "relevance_score": "0.455525", "ticker_sentiment_score": "-0.065276", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.238133", "ticker_sentiment_score": "-0.048379", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORN", "relevance_score": "0.238133", "ticker_sentiment_score": "-0.118855", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAND", "relevance_score": "0.238133", "ticker_sentiment_score": "-0.351125", "ticker_sentiment_label": "Bearish"}, {"ticker": "PINS", "relevance_score": "0.350564", "ticker_sentiment_score": "0.176056", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants", "url": "https://www.globenewswire.com/news-release/2024/06/14/2898753/0/en/Rezolute-Announces-Pricing-of-Public-Offering-of-60-Million-of-Common-Stock-and-Pre-Funded-Warrants.html", "time_published": "20240614T033000", "authors": ["Inc.", "Rezolute"], "summary": "NEW YORK, June 13, 2024 ( GLOBE NEWSWIRE ) -- Rezolute, Inc. ( Nasdaq: RZLT ) ( \"Rezolute\" or the \"Company\" ) , a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare diseases, today announced the pricing of its previously announced ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.983605"}, {"topic": "Financial Markets", "relevance_score": "0.99737"}], "overall_sentiment_score": 0.135725, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.263373", "ticker_sentiment_score": "0.222207", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Urban Outfitters Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Urban Outfitters  ( NASDAQ:URBN ) ", "url": "https://www.benzinga.com/news/24/05/38961979/why-urban-outfitters-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket", "time_published": "20240522T121623", "authors": ["Avi Kapoor"], "summary": "Shares of Urban Outfitters, Inc. URBN rose sharply in today's pre-market trading after the company reported better-than-expected financial results for its first quarter on Tuesday. The company reported quarterly earnings of 69 cents per share, which beat the analyst consensus estimate of 52 cents.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/22/xrdDAFj0FUZspA2-j5351515556-t23052408.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.882182"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.19776, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "XLYO", "relevance_score": "0.116631", "ticker_sentiment_score": "0.039392", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGRX", "relevance_score": "0.116631", "ticker_sentiment_score": "0.175132", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FLJ", "relevance_score": "0.116631", "ticker_sentiment_score": "-0.048714", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRLS", "relevance_score": "0.116631", "ticker_sentiment_score": "-0.048714", "ticker_sentiment_label": "Neutral"}, {"ticker": "CJET", "relevance_score": "0.116631", "ticker_sentiment_score": "-0.052486", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDBL", "relevance_score": "0.116631", "ticker_sentiment_score": "0.215854", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VRPX", "relevance_score": "0.174167", "ticker_sentiment_score": "-0.048967", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRKN", "relevance_score": "0.174167", "ticker_sentiment_score": "-0.039653", "ticker_sentiment_label": "Neutral"}, {"ticker": "URBN", "relevance_score": "0.174167", "ticker_sentiment_score": "0.228314", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EPRX", "relevance_score": "0.116631", "ticker_sentiment_score": "0.164357", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MGOL", "relevance_score": "0.174167", "ticker_sentiment_score": "0.30776", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BNED", "relevance_score": "0.116631", "ticker_sentiment_score": "0.170611", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RZLT", "relevance_score": "0.116631", "ticker_sentiment_score": "0.073712", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKTS", "relevance_score": "0.174167", "ticker_sentiment_score": "0.058778", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFST", "relevance_score": "0.174167", "ticker_sentiment_score": "0.176464", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VSAT", "relevance_score": "0.116631", "ticker_sentiment_score": "-0.177393", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SINT", "relevance_score": "0.116631", "ticker_sentiment_score": "-0.052486", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.058472", "ticker_sentiment_score": "0.040095", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSME", "relevance_score": "0.116631", "ticker_sentiment_score": "0.068127", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMFA", "relevance_score": "0.174167", "ticker_sentiment_score": "0.317299", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MBIO", "relevance_score": "0.116631", "ticker_sentiment_score": "0.193777", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Is Small-Cap Metabolic-Focused Rezolute Stock Trading Higher On Wednesday? - Rezolute  ( NASDAQ:RZLT ) ", "url": "https://www.benzinga.com/general/biotech/24/05/38961181/why-is-small-cap-metabolic-focused-rezolute-stock-trading-higher-on-wednesday", "time_published": "20240522T115606", "authors": ["Vandana Singh"], "summary": "Tuesday, Rezolute Inc RZLT released topline results from the Phase 2 study of RZ402 in diabetic macular edema patients who are na\u00efve to or have received limited anti-vascular growth factor ( anti-VEGF ) injections.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/22/RZLT.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.178733, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.317527", "ticker_sentiment_score": "0.118701", "ticker_sentiment_label": "Neutral"}]}, {"title": "Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics", "url": "https://www.globenewswire.com/news-release/2024/05/01/2873221/0/en/Samir-R-Patel-M-D-Appointed-Interim-CEO-for-Akari-Therapeutics.html", "time_published": "20240501T120100", "authors": ["Akari Therapeutics Plc"], "summary": "BOSTON and LONDON, May 01, 2024 ( GLOBE NEWSWIRE ) -- Akari Therapeutics, Plc ( Nasdaq: AKTX ) , a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced leadership changes, including the appointment of experienced life sciences entrepreneur ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/8d978f50-07a9-40a3-be69-45f51ccd94d9", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.997902"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.165176, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AKTX", "relevance_score": "0.105199", "ticker_sentiment_score": "0.149012", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURN", "relevance_score": "0.013188", "ticker_sentiment_score": "0.034002", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.013188", "ticker_sentiment_score": "0.024376", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.026372", "ticker_sentiment_score": "0.026929", "ticker_sentiment_label": "Neutral"}]}, {"title": "Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics - Akari Therapeutics  ( NASDAQ:AKTX ) , Peak Bio  ( OTC:PKBO ) ", "url": "https://www.benzinga.com/pressreleases/24/05/g38547749/samir-r-patel-m-d-appointed-interim-ceo-for-akari-therapeutics", "time_published": "20240501T120100", "authors": ["Globe Newswire"], "summary": "BOSTON and LONDON, May 01, 2024 ( GLOBE NEWSWIRE ) -- Akari Therapeutics, Plc AKTX, a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced leadership changes, including the appointment of experienced life sciences entrepreneur Samir R.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.998333"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.167436, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AKTX", "relevance_score": "0.10361", "ticker_sentiment_score": "0.147121", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURN", "relevance_score": "0.012987", "ticker_sentiment_score": "0.033928", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.012987", "ticker_sentiment_score": "0.024333", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.025971", "ticker_sentiment_score": "0.026861", "ticker_sentiment_label": "Neutral"}]}, {"title": "CommScope Holding And 2 Other Stocks Under $3 Insiders Are Buying - CommScope Hldg Co  ( NASDAQ:COMM ) , Agrify  ( NASDAQ:AGFY ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/04/38019139/commscope-holding-and-2-other-stocks-under-3-insiders-are-buying", "time_published": "20240401T111634", "authors": ["Avi Kapoor"], "summary": "The Dow Jones index closed higher by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.236889, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "COMM", "relevance_score": "0.520773", "ticker_sentiment_score": "0.268415", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GRSO", "relevance_score": "0.112532", "ticker_sentiment_score": "0.059443", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.520773", "ticker_sentiment_score": "0.239398", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AGFY", "relevance_score": "0.520773", "ticker_sentiment_score": "0.253716", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "$17M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying - Bespoke Extracts  ( OTC:BSPK ) , CPS Technologies  ( NASDAQ:CPSH ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/03/37841975/17m-bet-on-this-healthcare-stock-check-out-these-4-penny-stocks-insiders-are-aggressivel", "time_published": "20240320T105824", "authors": ["Avi Kapoor"], "summary": "The Dow Jones index closed higher by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/03/20/image33.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.256108, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HGBL", "relevance_score": "0.36472", "ticker_sentiment_score": "0.333842", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CPSH", "relevance_score": "0.446742", "ticker_sentiment_score": "0.392264", "ticker_sentiment_label": "Bullish"}, {"ticker": "RZLT", "relevance_score": "0.446742", "ticker_sentiment_score": "0.220948", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "$1.5M Bet On This Penny Stock? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying - Advantage Solutions  ( NASDAQ:ADV ) , Marpai  ( NASDAQ:MRAI ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/03/37581606/1-5m-bet-on-this-penny-stock-check-out-these-4-stocks-under-5-insiders-are-aggressively-", "time_published": "20240311T184633", "authors": ["Avi Kapoor"], "summary": "The Dow Jones index closed lower by around 0.2% on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/03/11/image45.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.258443, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.474958", "ticker_sentiment_score": "0.247451", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ADV", "relevance_score": "0.474958", "ticker_sentiment_score": "0.165127", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia  ( NICTH ) ", "url": "https://www.globenewswire.com/news-release/2024/03/06/2841293/0/en/Rezolute-Reports-Validation-of-the-Potential-Use-of-RZ358-for-Treatment-of-Non-Islet-Cell-Tumor-Hypoglycemia-NICTH.html", "time_published": "20240306T123000", "authors": ["Inc.", "Rezolute"], "summary": "Potential to more than double the addressable patient population living with hypoglycemia resulting from insulin receptor over-activation ( tumor hyperinsulinism ) Potential to more than double the addressable patient population living with hypoglycemia resulting from insulin receptor ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/165f8dbc-1fce-47b8-ac3f-0cf6fb4170cb/rezolute.png", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.088724, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.263657", "ticker_sentiment_score": "0.130887", "ticker_sentiment_label": "Neutral"}]}, {"title": "Lumen Technologies And 3 Other Stocks Under $3 Insiders Are Buying - Brightcove  ( NASDAQ:BCOV ) , Cyanotech  ( OTC:CYAN ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/02/37359997/lumen-technologies-and-3-other-stocks-under-3-insiders-are-buying", "time_published": "20240228T122126", "authors": ["Avi Kapoor"], "summary": "The Dow Jones index closed lower by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/02/28/image24.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.251801, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LUMN", "relevance_score": "0.489394", "ticker_sentiment_score": "0.471577", "ticker_sentiment_label": "Bullish"}, {"ticker": "CYAN", "relevance_score": "0.489394", "ticker_sentiment_score": "0.340616", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RZLT", "relevance_score": "0.489394", "ticker_sentiment_score": "0.230811", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BCOV", "relevance_score": "0.489394", "ticker_sentiment_score": "0.368426", "ticker_sentiment_label": "Bullish"}]}, {"title": "Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying - Charles & Colvard  ( NASDAQ:CTHR ) , Cosmos Health  ( NASDAQ:COSM ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/02/37260175/charles-colvard-and-3-other-stocks-under-2-insiders-are-buying", "time_published": "20240222T135144", "authors": ["Avi Kapoor"], "summary": "The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/02/22/image20.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.24149, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "COSM", "relevance_score": "0.473208", "ticker_sentiment_score": "0.407316", "ticker_sentiment_label": "Bullish"}, {"ticker": "INM", "relevance_score": "0.473208", "ticker_sentiment_score": "0.438558", "ticker_sentiment_label": "Bullish"}, {"ticker": "CTHR", "relevance_score": "0.473208", "ticker_sentiment_score": "0.086919", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.473208", "ticker_sentiment_score": "0.246893", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute And 3 Other Penny Stocks Insiders Are Buying - Citizens  ( NYSE:CIA ) , Beasley Broadcast Group  ( NASDAQ:BBGI ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/02/37234741/rezolute-and-3-other-penny-stocks-insiders-are-buying", "time_published": "20240221T132659", "authors": ["Avi Kapoor"], "summary": "The Dow Jones index closed lower by more than 60 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/02/21/image18.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.241509, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BBGI", "relevance_score": "0.469744", "ticker_sentiment_score": "0.208455", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CIA", "relevance_score": "0.384397", "ticker_sentiment_score": "0.344896", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RZLT", "relevance_score": "0.469744", "ticker_sentiment_score": "0.248767", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism", "url": "https://www.globenewswire.com/news-release/2024/01/23/2814018/0/en/Rezolute-Receives-Innovation-Passport-Designation-from-the-U-K-Innovative-Licensing-and-Access-Pathway-Steering-Group-for-RZ358-in-the-Treatment-of-Hypoglycemia-Due-to-Congenital-H.html", "time_published": "20240123T130000", "authors": ["Rezolute", "Inc."], "summary": "REDWOOD CITY, Calif., Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Rezolute, Inc. ( Nasdaq: RZLT ) , a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced that the U.K.", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.210783, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.360752", "ticker_sentiment_score": "0.269308", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket - argenx  ( NASDAQ:ARGX ) , Aclarion  ( NASDAQ:ACON ) ", "url": "https://www.benzinga.com/news/23/12/36322940/why-aclarion-shares-are-trading-higher-by-around-53-here-are-20-stocks-moving-premarket", "time_published": "20231220T133058", "authors": ["Avi Kapoor"], "summary": "Shares of Aclarion, Inc. ACON shares rose sharply in pre-market trading after the company was granted U.S. patent #11844601 for \"MR SPECTROSCOPY SYSTEM FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCS ( Severe Low Back Pain ) .\" Aclarion shares jumped 53.1% to $0.4480 in pre-market ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/20/image33.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.928769"}], "overall_sentiment_score": 0.056269, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PBLA", "relevance_score": "0.123209", "ticker_sentiment_score": "0.002363", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCS", "relevance_score": "0.183895", "ticker_sentiment_score": "0.063585", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLUE", "relevance_score": "0.183895", "ticker_sentiment_score": "0.189974", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LIDR", "relevance_score": "0.123209", "ticker_sentiment_score": "0.04606", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOGN", "relevance_score": "0.123209", "ticker_sentiment_score": "-0.216213", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PLBY", "relevance_score": "0.183895", "ticker_sentiment_score": "0.277996", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RZLT", "relevance_score": "0.183895", "ticker_sentiment_score": "-0.039597", "ticker_sentiment_label": "Neutral"}, {"ticker": "SECO", "relevance_score": "0.123209", "ticker_sentiment_score": "0.020572", "ticker_sentiment_label": "Neutral"}, {"ticker": "UCAR", "relevance_score": "0.183895", "ticker_sentiment_score": "-0.13751", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUVI", "relevance_score": "0.123209", "ticker_sentiment_score": "0.400014", "ticker_sentiment_label": "Bullish"}, {"ticker": "XAIR", "relevance_score": "0.183895", "ticker_sentiment_score": "0.330263", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "XLO", "relevance_score": "0.123209", "ticker_sentiment_score": "-0.202334", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FDX", "relevance_score": "0.123209", "ticker_sentiment_score": "-0.093093", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARGX", "relevance_score": "0.123209", "ticker_sentiment_score": "-0.027144", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACON", "relevance_score": "0.183895", "ticker_sentiment_score": "-0.138396", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema  ( \"DME\" ) ", "url": "https://www.globenewswire.com/news-release/2023/12/13/2795495/0/en/Rezolute-Completes-Enrollment-of-its-Phase-2-Study-in-Diabetic-Macular-Edema-DME.html", "time_published": "20231213T130000", "authors": ["Rezolute", "Inc."], "summary": "Plans to report topline data mid-second quarter 2024 Plans to report topline data mid-second quarter ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.14243, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.325208", "ticker_sentiment_score": "0.195904", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute to Participate in BTIG's 3rd Annual Ophthalmology Day - Rezolute  ( NASDAQ:RZLT ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35846791/rezolute-to-participate-in-btigs-3rd-annual-ophthalmology-day", "time_published": "20231117T130000", "authors": ["Globe Newswire"], "summary": "REDWOOD CITY, Calif., Nov. 17, 2023 ( GLOBE NEWSWIRE ) -- Rezolute, Inc. RZLT, a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced that the management team will participate in BTIG's 3rd Annual ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.182853, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.801457", "ticker_sentiment_score": "0.32514", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute to Participate in BTIG's 3rd Annual Ophthalmology Day", "url": "https://www.globenewswire.com/news-release/2023/11/17/2782535/0/en/Rezolute-to-Participate-in-BTIG-s-3rd-Annual-Ophthalmology-Day.html", "time_published": "20231117T130000", "authors": ["Inc.", "Rezolute"], "summary": "REDWOOD CITY, Calif., Nov. 17, 2023 ( GLOBE NEWSWIRE ) -- Rezolute, Inc. ( Nasdaq: RZLT ) , a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced that the management team will participate in ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.185659, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.564813", "ticker_sentiment_score": "0.263731", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute Receives Priority Medicines  ( PRIME )  Eligibility from European Medicines Agency for Enhanced Regulatory Support of RZ358 in Congenital Hyperinsulinism - Rezolute  ( NASDAQ:RZLT ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35284767/rezolute-receives-priority-medicines-prime-eligibility-from-european-medicines-agency-for-enhanced", "time_published": "20231017T120000", "authors": ["Globe Newswire"], "summary": "REDWOOD CITY, Calif., Oct. 17, 2023 ( GLOBE NEWSWIRE ) -- Rezolute, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.147498, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.406197", "ticker_sentiment_score": "0.181239", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday - Bristol-Myers Squibb Company Common Stock  ( NYSE:BMY ) , SenesTech, Inc. - Common Stock  ( NASDAQ:SNES ) ", "url": "https://www.benzinga.com/markets/options/23/10/35092508/stocks-that-hit-52-week-lows-on-wednesday", "time_published": "20231004T160117", "authors": ["Benzinga Insights"], "summary": "On Wednesday, 311 stocks hit new 52-week lows. Bristol-Myers Squibb Company Common Stock BMY is the largest company in terms of market cap to set a new 52-week low this morning. SenesTech, Inc. - Common Stock SNES was the smallest company by market cap to set a new 52-week low. A10 Networks, ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.024373, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATEN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLGC", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.097572", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.006354", "ticker_sentiment_score": "0.104513", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOVA", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "CERE", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASST", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087508", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVST", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGIC", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "BALY", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.094831", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLGT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVCR", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.066077", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTAIF", "relevance_score": "0.006354", "ticker_sentiment_score": "0.056254", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTLY", "relevance_score": "0.012708", "ticker_sentiment_score": "0.081144", "ticker_sentiment_label": "Neutral"}, {"ticker": "VABK", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.103629", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "DENN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNLC", "relevance_score": "0.012708", "ticker_sentiment_score": "0.051167", "ticker_sentiment_label": "Neutral"}, {"ticker": "GME", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMWL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHAB", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.08354", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNGO", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.103629", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCNI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTR", "relevance_score": "0.012708", "ticker_sentiment_score": "0.058861", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBB", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.082048", "ticker_sentiment_label": "Neutral"}, {"ticker": "RC", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.072267", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEE", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEHL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.014754", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTI", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075723", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07967", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNL", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.097572", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADXN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.077302", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVEI", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.066789", "ticker_sentiment_label": "Neutral"}, {"ticker": "REXR", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.094831", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIDS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACET", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "PENN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.005375", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWH", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075723", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAPT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWK", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.023051", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREQ", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEER", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHX", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.097572", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "PULM", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSD", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDEN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRQS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.084108", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRDN", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "LSDI", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNES", "relevance_score": "0.025413", "ticker_sentiment_score": "-0.047554", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATXS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRFX", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOVA", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004433", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEDG", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRN", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.103629", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFFN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003468", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNA", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOLF", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "AONC", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALIT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.072267", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "DQ", "relevance_score": "0.012708", "ticker_sentiment_score": "0.07063", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.088031", "ticker_sentiment_label": "Neutral"}, {"ticker": "FENC", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.094831", "ticker_sentiment_label": "Neutral"}, {"ticker": "UI", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.072267", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBAC", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSA", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "EE", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.069682", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAND", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIO", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCSI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00345", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBLG", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOK", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.023051", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMM", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "JGGCR", "relevance_score": "0.006354", "ticker_sentiment_score": "0.003316", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTHM", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCC", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHUN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004433", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMCI", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.103629", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHLS", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.096253", "ticker_sentiment_label": "Neutral"}, {"ticker": "AADI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFG", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "KZR", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.072267", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLGN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENV", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEXI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHCO", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONFO", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTZ", "relevance_score": "0.012708", "ticker_sentiment_score": "0.073595", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBSW", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004455", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBP", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003468", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTG", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNG", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVNC", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIG", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXFY", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKSH", "relevance_score": "0.006354", "ticker_sentiment_score": "-0.099392", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLFD", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.097572", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNB", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGII", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLYQ", "relevance_score": "0.006354", "ticker_sentiment_score": "-0.090814", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASIX", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCQEF", "relevance_score": "0.006354", "ticker_sentiment_score": "0.035779", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONX", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "BXRX", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDBL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGEN", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMNI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004433", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARA", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004433", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELBM", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "YGMZ", "relevance_score": "0.012708", "ticker_sentiment_score": "0.015818", "ticker_sentiment_label": "Neutral"}, {"ticker": "KVUE", "relevance_score": "0.012708", "ticker_sentiment_score": "0.073595", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERU", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.10115", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSKEF", "relevance_score": "0.006354", "ticker_sentiment_score": "0.089086", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSBX", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "MATV", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075723", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHPT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMXI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARV", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.006354", "ticker_sentiment_score": "0.093873", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGRX", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONR", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075835", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINC", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "HKIT", "relevance_score": "0.012708", "ticker_sentiment_score": "0.084108", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTCT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCEA", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEXPF", "relevance_score": "0.006354", "ticker_sentiment_score": "0.003316", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "STIM", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004455", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBP", "relevance_score": "0.012708", "ticker_sentiment_score": "0.077302", "ticker_sentiment_label": "Neutral"}, {"ticker": "IGMS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCTO", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "SATS", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKKT", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.025413", "ticker_sentiment_score": "-0.094732", "ticker_sentiment_label": "Neutral"}, {"ticker": "OGI", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTK", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRRX", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLFPF", "relevance_score": "0.012708", "ticker_sentiment_score": "0.145721", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGO", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.012708", "ticker_sentiment_score": "0.073595", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALK", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004433", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSIQ", "relevance_score": "0.012708", "ticker_sentiment_score": "0.09692", "ticker_sentiment_label": "Neutral"}, {"ticker": "TITN", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.097572", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHCT", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075723", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.006354", "ticker_sentiment_score": "0.004247", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBCP", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.097572", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOM", "relevance_score": "0.012708", "ticker_sentiment_score": "0.029644", "ticker_sentiment_label": "Neutral"}, {"ticker": "UDR", "relevance_score": "0.012708", "ticker_sentiment_score": "0.058861", "ticker_sentiment_label": "Neutral"}, {"ticker": "VFS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.09692", "ticker_sentiment_label": "Neutral"}, {"ticker": "MP", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "VWE", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075723", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAG", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSX", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "KROS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOX", "relevance_score": "0.006354", "ticker_sentiment_score": "0.056254", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004455", "ticker_sentiment_label": "Neutral"}, {"ticker": "MED", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIFS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANVS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "DISH", "relevance_score": "0.012708", "ticker_sentiment_score": "0.002574", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESTA", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.015601", "ticker_sentiment_label": "Neutral"}, {"ticker": "GERN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLPG", "relevance_score": "0.012708", "ticker_sentiment_score": "0.077302", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERAS", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.094831", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNTS", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFIN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "PARA", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.165618", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VRAR", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAND", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "INM", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.10115", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.006354", "ticker_sentiment_score": "0.077621", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLP", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.024164", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTOO", "relevance_score": "0.012708", "ticker_sentiment_score": "0.074399", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPR", "relevance_score": "0.006354", "ticker_sentiment_score": "0.004163", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUO", "relevance_score": "0.012708", "ticker_sentiment_score": "0.077302", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMFA", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPGC", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004433", "ticker_sentiment_label": "Neutral"}, {"ticker": "PMD", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "PB", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075723", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.012708", "ticker_sentiment_score": "0.055971", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRV", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "PI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPA", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIU", "relevance_score": "0.012708", "ticker_sentiment_score": "0.092908", "ticker_sentiment_label": "Neutral"}, {"ticker": "JACK", "relevance_score": "0.012708", "ticker_sentiment_score": "0.058861", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}]}, {"title": "Vial Announces October Session of \"First in Human: The Panel Series\" Featuring Esteemed Panelists Jen Watts, Dr. Raj Agrawal, and Bruno Gagnon", "url": "https://www.prnewswire.com/news-releases/vial-announces-october-session-of-first-in-human-the-panel-series-featuring-esteemed-panelists-jen-watts-dr-raj-agrawal-and-bruno-gagnon-301943750.html", "time_published": "20231001T230000", "authors": ["Vial"], "summary": "Vial Announces October Session of \"First in Human: The Panel Series\" Featuring Esteemed Panelists Jen Watts, Dr ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1724383/general_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.365894, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "OPT", "relevance_score": "0.118064", "ticker_sentiment_score": "0.082018", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.118064", "ticker_sentiment_score": "0.082018", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute Reports Full Year Fiscal 2023 Results and Highlights Company Progress", "url": "https://www.globenewswire.com/news-release/2023/09/14/2743656/0/en/Rezolute-Reports-Full-Year-Fiscal-2023-Results-and-Highlights-Company-Progress.html", "time_published": "20230914T200500", "authors": ["Inc.", "Rezolute"], "summary": "Planning to initiate Phase 3 Study for RZ358 ( \"sunRIZE study\" ) in the fourth quarter of 2023 Planning to initiate Phase 3 Study for RZ358 ( \"sunRIZE study\" ) in the fourth quarter of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.090358, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.410871", "ticker_sentiment_score": "0.089771", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute And 2 Other Penny Stocks Insiders Are Aggressively Buying - BioCorRx  ( OTC:BICX ) , Cadiz  ( NASDAQ:CDZI ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/07/33146912/rezolute-and-2-other-penny-stocks-insiders-are-aggressively-buying", "time_published": "20230707T125957", "authors": ["Lisa Levin"], "summary": "The Dow Jones closed lower by over 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/07/07/rezolute_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}], "overall_sentiment_score": 0.170358, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.567746", "ticker_sentiment_score": "0.221664", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CDZI", "relevance_score": "0.567746", "ticker_sentiment_score": "0.435619", "ticker_sentiment_label": "Bullish"}]}, {"title": "Rezolute to Initiate a Pivotal Phase 3 Study of RZ358 in Participants 3 Months of Age and Older with Congenital Hyperinsulinism", "url": "https://www.globenewswire.com/news-release/2023/06/27/2695775/0/en/Rezolute-to-Initiate-a-Pivotal-Phase-3-Study-of-RZ358-in-Participants-3-Months-of-Age-and-Older-with-Congenital-Hyperinsulinism.html", "time_published": "20230627T200500", "authors": ["Rezolute", "Inc."], "summary": "Study to be initiated in Europe and other ex-US geographies in Q4 2023, with topline results expected ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.576289"}], "overall_sentiment_score": 0.088599, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.374096", "ticker_sentiment_score": "0.154072", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy", "url": "https://www.globenewswire.com/news-release/2023/05/09/2664299/7281/en/XOMA-Reports-First-Quarter-2023-Financial-Results-and-Provides-Update-on-the-Acceleration-of-its-Differentiated-Royalty-Monetization-Strategy.html", "time_published": "20230509T113000", "authors": ["XOMA Corporation"], "summary": "First quarter with incoming cashflows from two commercial assets ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/46cbb269-1ae4-4441-a46a-d782ffb436dc", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.995973"}, {"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.167547, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.063258", "ticker_sentiment_score": "0.134102", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema", "url": "https://www.globenewswire.com/news-release/2023/03/23/2633679/0/en/Rezolute-KOL-Event-Highlights-Significant-Unmet-Medical-Need-in-Diabetic-Macular-Edema.html", "time_published": "20230323T205000", "authors": ["Inc.", "Rezolute"], "summary": "RZ402 is an oral therapy being developed as a potential alternative to anti-vascular growth factor ( anti-VEGF ) injections into the eye RZ402 is an oral therapy being developed as a potential alternative to anti-vascular growth factor ( anti-VEGF ) injections into the eye ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.084462, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.340915", "ticker_sentiment_score": "0.141464", "ticker_sentiment_label": "Neutral"}]}, {"title": "XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy", "url": "https://www.globenewswire.com/news-release/2023/03/09/2623956/7281/en/XOMA-Reports-Full-Year-2022-Financial-Results-and-Provides-Update-to-the-Acceleration-of-its-Differentiated-Royalty-Monetization-Strategy.html", "time_published": "20230309T123000", "authors": ["XOMA Corporation"], "summary": "2022 was the first year with cash receipts from a commercial asset since becoming a royalty aggregator ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/46cbb269-1ae4-4441-a46a-d782ffb436dc?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.995973"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.183711, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CGEN", "relevance_score": "0.051276", "ticker_sentiment_score": "0.049622", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.025651", "ticker_sentiment_score": "0.044938", "ticker_sentiment_label": "Neutral"}, {"ticker": "OGN", "relevance_score": "0.025651", "ticker_sentiment_score": "-0.063269", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute Reports Second Quarter Fiscal 2023 Results and Highlights Company Progress", "url": "https://www.globenewswire.com/news-release/2023/02/10/2606210/0/en/Rezolute-Reports-Second-Quarter-Fiscal-2023-Results-and-Highlights-Company-Progress.html", "time_published": "20230210T210500", "authors": ["Inc.", "Rezolute"], "summary": "Initiated Phase 2 proof-of-concept study of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.905476"}], "overall_sentiment_score": 0.118303, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.504646", "ticker_sentiment_score": "0.16193", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute to Present at the Jefferies London Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2022/11/01/2545290/0/en/Rezolute-to-Present-at-the-Jefferies-London-Healthcare-Conference.html", "time_published": "20221101T110000", "authors": ["Inc.", "Rezolute"], "summary": "REDWOOD CITY, Calif., Nov. 01, 2022 ( GLOBE NEWSWIRE ) -- Rezolute, Inc. ( Nasdaq: RZLT ) , a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to shift the treatment paradigms of devastating metabolic diseases, today announced that ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.123742, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.668247", "ticker_sentiment_score": "0.192264", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute Announces Presentation at The Retina Society 55th Annual Scientific Meeting - Rezolute  ( NASDAQ:RZLT ) ", "url": "https://www.benzinga.com/pressreleases/22/10/g29337860/rezolute-announces-presentation-at-the-retina-society-55th-annual-scientific-meeting", "time_published": "20221020T110000", "authors": ["Globe Newswire"], "summary": "REDWOOD CITY, Calif., Oct. 20, 2022 ( GLOBE NEWSWIRE ) -- Rezolute, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.068042, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.677342", "ticker_sentiment_score": "0.118434", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:VND", "relevance_score": "0.130926", "ticker_sentiment_score": "0.023801", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute Announces Presentation at The Retina Society 55th Annual Scientific Meeting", "url": "https://www.globenewswire.com/news-release/2022/10/20/2538145/0/en/Rezolute-Announces-Presentation-at-The-Retina-Society-55th-Annual-Scientific-Meeting.html", "time_published": "20221020T110000", "authors": ["Inc.", "Rezolute"], "summary": "REDWOOD CITY, Calif., Oct. 20, 2022 ( GLOBE NEWSWIRE ) -- Rezolute, Inc. ( Nasdaq: RZLT ) , a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to shift the treatment paradigms of devastating metabolic diseases, today announced it will ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.095689, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.551805", "ticker_sentiment_score": "0.138594", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:VND", "relevance_score": "0.067158", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute, Inc.  ( RZLT )  Upgraded to Buy: Here's Why", "url": "https://www.zacks.com/stock/news/1983225/rezolute-inc-rzlt-upgraded-to-buy-heres-why", "time_published": "20220921T160006", "authors": ["Zacks Investment Research"], "summary": "Rezolute, Inc. (RZLT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default226.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.692272"}], "overall_sentiment_score": 0.318733, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.363388", "ticker_sentiment_score": "0.372271", "ticker_sentiment_label": "Bullish"}]}, {"title": "XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events", "url": "https://www.globenewswire.com/news-release/2022/08/04/2492213/7281/en/XOMA-Reports-Second-Quarter-2022-Financial-Results-and-Highlights-Recent-Operational-Events.html", "time_published": "20220804T113000", "authors": ["XOMA Corporation"], "summary": "The completion of Regeneron's acquisition of Checkmate Pharmaceuticals resulted in a $5 million milestone payment to Kuros, $2.5 million of which was paid to XOMA in July.", "banner_image": "https://ml.globenewswire.com/Resource/Download/34238cc4-fde6-4d9b-baba-b210eb5123a1?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.961735"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.184002, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.18967", "ticker_sentiment_score": "0.179742", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SONN", "relevance_score": "0.031907", "ticker_sentiment_score": "0.147206", "ticker_sentiment_label": "Neutral"}]}, {"title": "Short Volatility Alert: Rezolute, Inc.", "url": "https://www.benzinga.com/markets/penny-stocks/22/06/27607944/short-volatility-alert-rezolute-inc", "time_published": "20220608T134119", "authors": ["Christopher Sappo"], "summary": "On Tuesday, shares of Rezolute, Inc. RZLT experienced volatile short activity. After the activity, the stock price went down -2.59% to $3.01. The overall sentiment for RZLT has been Bearish. The signal from the volatility alert is trending Bearish. Therefore, the recommendation is to Strong Sell.", "banner_image": "https://cdn.benzinga.com/files/short_image_73.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.989041"}], "overall_sentiment_score": -0.091558, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.330286", "ticker_sentiment_score": "-0.295563", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Rezolute Announces Promotion of Brian Roberts, M.D. to Chief Medical Officer", "url": "https://www.globenewswire.com/news-release/2022/06/01/2454045/0/en/Rezolute-Announces-Promotion-of-Brian-Roberts-M-D-to-Chief-Medical-Officer.html", "time_published": "20220601T110000", "authors": ["Rezolute", "Inc."], "summary": "REDWOOD CITY, Calif., June 01, 2022 ( GLOBE NEWSWIRE ) -- Rezolute, Inc. ( Nasdaq: RZLT ) , a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to disrupt current treatment paradigms for devastating metabolic diseases, today announced t", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.311657, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FGEN", "relevance_score": "0.044288", "ticker_sentiment_score": "0.019752", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.56313", "ticker_sentiment_score": "0.311657", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute Announces Promotion of Brian Roberts, M.D. to Chief Medical Officer", "url": "https://www.benzinga.com/pressreleases/22/06/g27493975/rezolute-announces-promotion-of-brian-roberts-m-d-to-chief-medical-officer", "time_published": "20220601T110000", "authors": ["Globe Newswire"], "summary": "REDWOOD CITY, Calif., June 01, 2022 ( GLOBE NEWSWIRE ) -- Rezolute, Inc. ( NASDAQ:RZLT ) , a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to disrupt current treatment paradigms for devastating metabolic diseases, today announced th", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.30624, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FGEN", "relevance_score": "0.043642", "ticker_sentiment_score": "0.019752", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.556409", "ticker_sentiment_score": "0.317842", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute, Inc. Announces Closing of Registered Direct Offering", "url": "https://www.globenewswire.com/news-release/2022/05/04/2435821/0/en/Rezolute-Inc-Announces-Closing-of-Registered-Direct-Offering.html", "time_published": "20220504T133300", "authors": ["Inc.", "Rezolute"], "summary": "REDWOOD CITY, Calif., May  04, 2022   ( GLOBE NEWSWIRE )  -- Rezolute, Inc.  ( Nasdaq: RZLT ) , a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to disrupt current treatment paradigms for devastating metabolic diseases, today announced th", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.682689"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.07808, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "JHG", "relevance_score": "0.033637", "ticker_sentiment_score": "0.00596", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCORF", "relevance_score": "0.033637", "ticker_sentiment_score": "0.001017", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.033637", "ticker_sentiment_score": "0.00596", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.357262", "ticker_sentiment_score": "0.099792", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute's RZ358 Shows Around 75% Reduction In Hypoglycemia Events", "url": "https://www.benzinga.com/general/biotech/22/05/26924201/rezolutes-rz358-shows-around-75-reduction-in-hypoglycemia-events", "time_published": "20220502T115138", "authors": ["Vandana Singh"], "summary": "Rezolute Inc  ( NASDAQ: RZLT )  unveiled results from its Phase 2b RIZE study of RZ358 in patients with congenital hyperinsulinism  ( abnormally high insulin levels )  at the Pediatric Endocrine Society 2022 Annual Meeting. \nRZ358 showed a better than 50% reduction from baseline in overall and sever", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/02/aapharma_1.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.036487, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.729595", "ticker_sentiment_score": "0.002213", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute, Inc. Announces Aggregate $130 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market", "url": "https://www.benzinga.com/pressreleases/22/05/g26922638/rezolute-inc-announces-aggregate-130-million-registered-direct-offering-and-concurrent-private-pla", "time_published": "20220502T032514", "authors": ["Globe Newswire"], "summary": "REDWOOD CITY, Calif., May  01, 2022   ( GLOBE NEWSWIRE )  -- Rezolute, Inc.  ( NASDAQ:RZLT ) , a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to disrupt current treatment paradigms for devastating metabolic diseases, today announced the", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.682689"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.074378, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CCORF", "relevance_score": "0.078883", "ticker_sentiment_score": "0.002499", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.379492", "ticker_sentiment_score": "0.121918", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute, Inc. Announces Aggregate $130 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market", "url": "https://www.globenewswire.com/news-release/2022/05/02/2433099/0/en/Rezolute-Inc-Announces-Aggregate-130-Million-Registered-Direct-Offering-and-Concurrent-Private-Placement-Priced-At-the-Market.html", "time_published": "20220502T032500", "authors": ["Rezolute", "Inc."], "summary": "REDWOOD CITY, Calif., May  01, 2022   ( GLOBE NEWSWIRE )  -- Rezolute, Inc.  ( Nasdaq: RZLT ) , a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to disrupt current treatment paradigms for devastating metabolic diseases, today announced th", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.682689"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.065694, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CCORF", "relevance_score": "0.060055", "ticker_sentiment_score": "0.002499", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.348756", "ticker_sentiment_score": "0.086554", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute Announces Positive Data from its Phase 2b  ( RIZE )  Study of RZ358 in Patients with Congenital Hyperinsulinism", "url": "https://www.globenewswire.com/news-release/2022/05/01/2433077/0/en/Rezolute-Announces-Positive-Data-from-its-Phase-2b-RIZE-Study-of-RZ358-in-Patients-with-Congenital-Hyperinsulinism.html", "time_published": "20220501T180000", "authors": ["Rezolute", "Inc."], "summary": "Results Presented Today at the Pediatric Endocrine Society's 2022 Annual Meeting Results Presented Today at the Pediatric Endocrine Society's 2022 Annual Meeting", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.221099, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.21332", "ticker_sentiment_score": "0.221099", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rezolute Announces Positive Data from its Phase 2b  ( RIZE )  Study of RZ358 in Patients with Congenital Hyperinsulinism", "url": "https://www.benzinga.com/pressreleases/22/05/g26921736/rezolute-announces-positive-data-from-its-phase-2b-rize-study-of-rz358-in-patients-with-congenital", "time_published": "20220501T180000", "authors": ["Globe Newswire"], "summary": "Highly significant ~75% reduction in hypoglycemia events at anticipated therapeutic doses\n\u226550% improvement in hypoglycemia in 100% of patients in high-dose cohort, with no adverse drug reactions or clinically significant hyperglycemia\nStudy exceeded expectations for correction of hypoglycemia across", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.213854, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.203869", "ticker_sentiment_score": "0.223743", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "12 Health Care Stocks Moving In Monday's Pre-Market Session", "url": "https://www.benzinga.com/pre-market-outlook/22/04/26663649/12-health-care-stocks-moving-in-mondays-pre-market-session", "time_published": "20220418T131808", "authors": [], "summary": "Gainers\nNatus Medical  ( NASDAQ:NTUS )  stock rose 28.3% to $33.42 during Monday's pre-market session. The market value of their outstanding shares is at $1.1 billion.\nNeuroBo Pharmaceuticals  ( NASDAQ:NRBO )  shares moved upwards by 12.73% to $0.98. The market value of their outstanding shares is a", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_6713.jpeg", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": -0.001647, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NTUS", "relevance_score": "0.13775", "ticker_sentiment_score": "0.009589", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.13775", "ticker_sentiment_score": "-0.000941", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVEO", "relevance_score": "0.13775", "ticker_sentiment_score": "-0.003795", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMRA", "relevance_score": "0.13775", "ticker_sentiment_score": "0.002416", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVIV", "relevance_score": "0.13775", "ticker_sentiment_score": "0.000785", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWAY", "relevance_score": "0.13775", "ticker_sentiment_score": "-0.039723", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADVM", "relevance_score": "0.13775", "ticker_sentiment_score": "0.002162", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRBO", "relevance_score": "0.13775", "ticker_sentiment_score": "0.001087", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.13775", "ticker_sentiment_score": "0.005002", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSGM", "relevance_score": "0.13775", "ticker_sentiment_score": "0.000745", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.13775", "ticker_sentiment_score": "0.000418", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.13775", "ticker_sentiment_score": "-0.001493", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute Joins the Rare Disease Company Coalition", "url": "https://www.globenewswire.com/news-release/2022/03/29/2411718/0/en/Rezolute-Joins-the-Rare-Disease-Company-Coalition.html", "time_published": "20220329T110000", "authors": ["Inc.", "Rezolute"], "summary": "Rezolute joins group aimed at helping advance timely access to life-saving therapies for those impacted by rare diseases Rezolute joins group aimed at helping advance timely access to life-saving therapies for those impacted by rare diseases", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.363189, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.542897", "ticker_sentiment_score": "0.363189", "ticker_sentiment_label": "Bullish"}]}, {"title": "36 Stocks Moving In Friday's Mid-Day Session", "url": "https://www.benzinga.com/news/22/03/26300873/36-stocks-moving-in-fridays-mid-day-session", "time_published": "20220325T160459", "authors": [], "summary": "Gainers\nForge Global Holdings, Inc.   ( NYSE: FRGE )  shares jumped 66.4% to $20.70.\nClever Leaves Holdings Inc.  ( NASDAQ: CLVR )  jumped 29.1% to $2.04 after the company reported better-than-expected Q4 sales results and reaffirmed FY22 guidance.\nJoby Aviation, Inc.  ( NYSE: JOBY )  shares gained ", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_148.jpg", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.99915"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.154889, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ASAN", "relevance_score": "0.153994", "ticker_sentiment_score": "0.00053", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCFT", "relevance_score": "0.10302", "ticker_sentiment_score": "-0.001571", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.153994", "ticker_sentiment_score": "0.001856", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLP", "relevance_score": "0.051618", "ticker_sentiment_score": "-0.001485", "ticker_sentiment_label": "Neutral"}, {"ticker": "RADA", "relevance_score": "0.10302", "ticker_sentiment_score": "-0.001485", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCR", "relevance_score": "0.051618", "ticker_sentiment_score": "0.000248", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.10302", "ticker_sentiment_score": "-0.001155", "ticker_sentiment_label": "Neutral"}, {"ticker": "CEIX", "relevance_score": "0.10302", "ticker_sentiment_score": "0.001062", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.10302", "ticker_sentiment_score": "0.00026", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENFN", "relevance_score": "0.10302", "ticker_sentiment_score": "-0.001899", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLRY", "relevance_score": "0.10302", "ticker_sentiment_score": "0.003322", "ticker_sentiment_label": "Neutral"}, {"ticker": "BILI", "relevance_score": "0.10302", "ticker_sentiment_score": "7.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEIP", "relevance_score": "0.10302", "ticker_sentiment_score": "-0.439021", "ticker_sentiment_label": "Bearish"}, {"ticker": "CODX", "relevance_score": "0.10302", "ticker_sentiment_score": "-8.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUN", "relevance_score": "0.10302", "ticker_sentiment_score": "8.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBP", "relevance_score": "0.10302", "ticker_sentiment_score": "0.002056", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFY", "relevance_score": "0.153994", "ticker_sentiment_score": "-0.474896", "ticker_sentiment_label": "Bearish"}, {"ticker": "SPRC", "relevance_score": "0.10302", "ticker_sentiment_score": "0.00425", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIDI", "relevance_score": "0.10302", "ticker_sentiment_score": "0.000328", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGGF", "relevance_score": "0.051618", "ticker_sentiment_score": "-0.001485", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRN", "relevance_score": "0.10302", "ticker_sentiment_score": "-0.6341", "ticker_sentiment_label": "Bearish"}, {"ticker": "CUTR", "relevance_score": "0.10302", "ticker_sentiment_score": "-0.013295", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAN", "relevance_score": "0.051618", "ticker_sentiment_score": "-0.000453", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAVE", "relevance_score": "0.10302", "ticker_sentiment_score": "-0.000299", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIO", "relevance_score": "0.153994", "ticker_sentiment_score": "0.030195", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.10302", "ticker_sentiment_score": "-0.007725", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.10302", "ticker_sentiment_score": "-0.002911", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVR", "relevance_score": "0.10302", "ticker_sentiment_score": "0.01622", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMRT", "relevance_score": "0.10302", "ticker_sentiment_score": "-0.410957", "ticker_sentiment_label": "Bearish"}, {"ticker": "ICVX", "relevance_score": "0.10302", "ticker_sentiment_score": "-0.330537", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JOBY", "relevance_score": "0.10302", "ticker_sentiment_score": "0.006535", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute  ( RZLT )  Posts Positive Data From Congenital HI Study", "url": "https://www.zacks.com/stock/news/1887111/rezolute-rzlt-posts-positive-data-from-congenital-hi-study", "time_published": "20220324T180200", "authors": ["Zacks Investment Research"], "summary": "Rezolute (RZLT) releases favorable data from the phase IIb RIZE study on its lead candidate RZ358, currently being investigated for congenital hyperinsulinism.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/62/5473.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.02609, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.229945", "ticker_sentiment_score": "0.032107", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.303269", "ticker_sentiment_score": "-0.008913", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.619463", "ticker_sentiment_score": "0.061132", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLDO", "relevance_score": "0.303269", "ticker_sentiment_score": "-0.028768", "ticker_sentiment_label": "Neutral"}]}, {"title": "12 Health Care Stocks Moving In Wednesday's Pre-Market Session", "url": "https://www.benzinga.com/pre-market-outlook/22/03/26257590/12-health-care-stocks-moving-in-wednesdays-pre-market-session", "time_published": "20220323T130750", "authors": [], "summary": "Gainers\nCreative Medical Tech  ( NASDAQ:CELZ )  shares rose 78.8% to $3.04 during Wednesday's pre-market session. The market value of their outstanding shares is at $19.2 million.\n4d pharma  ( NASDAQ:LBPS )  shares rose 55.06% to $7.24. The market value of their outstanding shares is at $163.1 milli", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_4930.jpeg", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.000554, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CING", "relevance_score": "0.137592", "ticker_sentiment_score": "-0.000921", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTS", "relevance_score": "0.137592", "ticker_sentiment_score": "-0.002169", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAXX", "relevance_score": "0.137592", "ticker_sentiment_score": "-0.000259", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLG", "relevance_score": "0.137592", "ticker_sentiment_score": "-0.002462", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRSN", "relevance_score": "0.137592", "ticker_sentiment_score": "0.003917", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.137592", "ticker_sentiment_score": "0.001751", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALA", "relevance_score": "0.137592", "ticker_sentiment_score": "-0.001592", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.137592", "ticker_sentiment_score": "-0.000388", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBPS", "relevance_score": "0.137592", "ticker_sentiment_score": "0.003839", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGLS", "relevance_score": "0.137592", "ticker_sentiment_score": "0.002192", "ticker_sentiment_label": "Neutral"}, {"ticker": "FEMY", "relevance_score": "0.137592", "ticker_sentiment_score": "0.003001", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rezolute Announces Positive Results from the Phase 2b RIZE Study of RZ358 in Congenital Hyperinsulinism", "url": "https://www.globenewswire.com/news-release/2022/03/23/2408363/0/en/Rezolute-Announces-Positive-Results-from-the-Phase-2b-RIZE-Study-of-RZ358-in-Congenital-Hyperinsulinism.html", "time_published": "20220323T110000", "authors": ["Inc.", "Rezolute"], "summary": "The RIZE study demonstrated highly significant improvements in hypoglycemia and good safety and tolerability", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbe03de3-6870-4230-b875-d8965a3d1b97?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.382672, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "RZLT", "relevance_score": "0.417074", "ticker_sentiment_score": "0.382672", "ticker_sentiment_label": "Bullish"}]}, {"title": "58 Biggest Movers From Friday", "url": "https://www.benzinga.com/news/22/03/26214817/58-biggest-movers-from-friday", "time_published": "20220321T085447", "authors": [], "summary": "Gainers\nBEST Inc.  ( NYSE: BEST )  shares gained 73.6% to close at $1.00.\nDiDi Global Inc.   ( NYSE: DIDI )  shares jumped 59.8% to settle at $4.09 on Friday.\nZhihu Inc.  ( NYSE: ZH )  jumped 54.9% to settle at $3.16.\nRezolute, Inc.  ( NASDAQ: RZLT )  gained 52.4% to close at $4.10.\nRedbox Entertain", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_414.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.994953"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.020617, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AHG", "relevance_score": "0.072699", "ticker_sentiment_score": "0.001024", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPEV", "relevance_score": "0.072699", "ticker_sentiment_score": "0.001651", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHI", "relevance_score": "0.072699", "ticker_sentiment_score": "0.002673", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTLB", "relevance_score": "0.072699", "ticker_sentiment_score": "0.003876", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIGR", "relevance_score": "0.10886", "ticker_sentiment_score": "0.006075", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPC", "relevance_score": "0.072699", "ticker_sentiment_score": "0.00135", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEDU", "relevance_score": "0.072699", "ticker_sentiment_score": "0.001328", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOHO", "relevance_score": "0.10886", "ticker_sentiment_score": "0.000867", "ticker_sentiment_label": "Neutral"}, {"ticker": "JOAN", "relevance_score": "0.10886", "ticker_sentiment_score": "-0.451876", "ticker_sentiment_label": "Bearish"}, {"ticker": "QTT", "relevance_score": "0.072699", "ticker_sentiment_score": "0.002253", "ticker_sentiment_label": "Neutral"}, {"ticker": "YI", "relevance_score": "0.072699", "ticker_sentiment_score": "-0.010459", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYMX", "relevance_score": "0.072699", "ticker_sentiment_score": "0.001547", "ticker_sentiment_label": "Neutral"}, {"ticker": "UK", "relevance_score": "0.072699", "ticker_sentiment_score": "0.00191", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDS", "relevance_score": "0.072699", "ticker_sentiment_score": "0.00079", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSFTF", "relevance_score": "0.036387", "ticker_sentiment_score": "0.003463", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDH", "relevance_score": "0.10886", "ticker_sentiment_score": "0.0081", "ticker_sentiment_label": "Neutral"}, {"ticker": "THRX", "relevance_score": "0.10886", "ticker_sentiment_score": "-0.00335", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENT", "relevance_score": "0.072699", "ticker_sentiment_score": "0.002564", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIH", "relevance_score": "0.072699", "ticker_sentiment_score": "0.006316", "ticker_sentiment_label": "Neutral"}, {"ticker": "EM", "relevance_score": "0.072699", "ticker_sentiment_score": "0.002945", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROM", "relevance_score": "0.072699", "ticker_sentiment_score": "0.007831", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.072699", "ticker_sentiment_score": "0.002751", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLGDF", "relevance_score": "0.036387", "ticker_sentiment_score": "0.08305", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRKR", "relevance_score": "0.072699", "ticker_sentiment_score": "0.00468", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.072699", "ticker_sentiment_score": "0.000444", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWNT", "relevance_score": "0.072699", "ticker_sentiment_score": "0.000156", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZH", "relevance_score": "0.072699", "ticker_sentiment_score": "0.002304", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAR", "relevance_score": "0.10886", "ticker_sentiment_score": "-0.000399", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCEL", "relevance_score": "0.072699", "ticker_sentiment_score": "0.000956", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAGS", "relevance_score": "0.072699", "ticker_sentiment_score": "0.000493", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONN", "relevance_score": "0.10886", "ticker_sentiment_score": "0.001919", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNM", "relevance_score": "0.072699", "ticker_sentiment_score": "0.008248", "ticker_sentiment_label": "Neutral"}, {"ticker": "STNEV", "relevance_score": "0.036387", "ticker_sentiment_score": "0.002848", "ticker_sentiment_label": "Neutral"}, {"ticker": "KODK", "relevance_score": "0.072699", "ticker_sentiment_score": "0.000589", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIZI", "relevance_score": "0.072699", "ticker_sentiment_score": "-5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGM", "relevance_score": "0.10886", "ticker_sentiment_score": "0.001489", "ticker_sentiment_label": "Neutral"}, {"ticker": "KC", "relevance_score": "0.072699", "ticker_sentiment_score": "0.003463", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIGI", "relevance_score": "0.072699", "ticker_sentiment_score": "0.001297", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDX", "relevance_score": "0.10886", "ticker_sentiment_score": "-0.243644", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HUIZ", "relevance_score": "0.072699", "ticker_sentiment_score": "0.008172", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEON", "relevance_score": "0.10886", "ticker_sentiment_score": "0.00406", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMGI", "relevance_score": "0.072699", "ticker_sentiment_score": "0.003281", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIDI", "relevance_score": "0.072699", "ticker_sentiment_score": "0.00346", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICD", "relevance_score": "0.072699", "ticker_sentiment_score": "0.008043", "ticker_sentiment_label": "Neutral"}, {"ticker": "TUYA", "relevance_score": "0.10886", "ticker_sentiment_score": "-0.014712", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.036387", "ticker_sentiment_score": "0.019701", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBFM", "relevance_score": "0.072699", "ticker_sentiment_score": "0.010208", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEON", "relevance_score": "0.072699", "ticker_sentiment_score": "0.001414", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBC", "relevance_score": "0.072699", "ticker_sentiment_score": "-0.000659", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAVE", "relevance_score": "0.072699", "ticker_sentiment_score": "0.009346", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIK", "relevance_score": "0.072699", "ticker_sentiment_score": "0.019701", "ticker_sentiment_label": "Neutral"}, {"ticker": "JVA", "relevance_score": "0.072699", "ticker_sentiment_score": "0.014459", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRZN", "relevance_score": "0.072699", "ticker_sentiment_score": "0.000478", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.072699", "ticker_sentiment_score": "0.003262", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBAI", "relevance_score": "0.072699", "ticker_sentiment_score": "0.000748", "ticker_sentiment_label": "Neutral"}, {"ticker": "TROO", "relevance_score": "0.072699", "ticker_sentiment_score": "0.001138", "ticker_sentiment_label": "Neutral"}, {"ticker": "APCX", "relevance_score": "0.072699", "ticker_sentiment_score": "0.002062", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEST", "relevance_score": "0.072699", "ticker_sentiment_score": "0.079839", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTK", "relevance_score": "0.072699", "ticker_sentiment_score": "0.000659", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:RUB", "relevance_score": "0.036387", "ticker_sentiment_score": "0.00406", "ticker_sentiment_label": "Neutral"}]}, {"title": "45 Stocks Moving In Friday's Mid-Day Session", "url": "https://www.benzinga.com/news/22/03/26202986/45-stocks-moving-in-fridays-mid-day-session", "time_published": "20220318T161811", "authors": [], "summary": "Gainers\nGrom Social Enterprises, Inc.  ( NASDAQ: GROM )  jumped 62.4% to $1.5500.\nDiDi Global Inc.   ( NYSE: DIDI )  shares climbed 46% to $3.73.\nKidpik Corp.   ( NASDAQ: PIK )  shares jumped 45.8% to $6.93 on continued momentum following the company's recently-announced partnership with The Walt Di", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_143.jpg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.997335"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.028557, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "XPEV", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000784", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTLB", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000436", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCAT", "relevance_score": "0.095593", "ticker_sentiment_score": "-0.021889", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLG", "relevance_score": "0.142961", "ticker_sentiment_score": "0.115526", "ticker_sentiment_label": "Neutral"}, {"ticker": "STNEV", "relevance_score": "0.047883", "ticker_sentiment_score": "0.001006", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIGR", "relevance_score": "0.142961", "ticker_sentiment_score": "0.004054", "ticker_sentiment_label": "Neutral"}, {"ticker": "KODK", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000304", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPC", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000534", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOHO", "relevance_score": "0.142961", "ticker_sentiment_score": "0.000701", "ticker_sentiment_label": "Neutral"}, {"ticker": "JOAN", "relevance_score": "0.142961", "ticker_sentiment_score": "-0.505908", "ticker_sentiment_label": "Bearish"}, {"ticker": "YI", "relevance_score": "0.095593", "ticker_sentiment_score": "-0.002171", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGM", "relevance_score": "0.142961", "ticker_sentiment_score": "0.000456", "ticker_sentiment_label": "Neutral"}, {"ticker": "UK", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000163", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDS", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000519", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSFTF", "relevance_score": "0.047883", "ticker_sentiment_score": "0.000683", "ticker_sentiment_label": "Neutral"}, {"ticker": "SJ", "relevance_score": "0.095593", "ticker_sentiment_score": "8.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "KC", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000683", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDH", "relevance_score": "0.142961", "ticker_sentiment_score": "0.000596", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDX", "relevance_score": "0.142961", "ticker_sentiment_score": "-0.181025", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HUIZ", "relevance_score": "0.095593", "ticker_sentiment_score": "0.003201", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENT", "relevance_score": "0.095593", "ticker_sentiment_score": "0.001868", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNAY", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000256", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEON", "relevance_score": "0.142961", "ticker_sentiment_score": "0.003185", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROM", "relevance_score": "0.095593", "ticker_sentiment_score": "0.00063", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000334", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIDI", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000782", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICD", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000382", "ticker_sentiment_label": "Neutral"}, {"ticker": "TUYA", "relevance_score": "0.142961", "ticker_sentiment_score": "-0.007637", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZH", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000168", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.047883", "ticker_sentiment_score": "0.013262", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBFM", "relevance_score": "0.095593", "ticker_sentiment_score": "0.005763", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEON", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000234", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBC", "relevance_score": "0.095593", "ticker_sentiment_score": "-8.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIK", "relevance_score": "0.095593", "ticker_sentiment_score": "0.013262", "ticker_sentiment_label": "Neutral"}, {"ticker": "JVA", "relevance_score": "0.095593", "ticker_sentiment_score": "0.005268", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOND", "relevance_score": "0.095593", "ticker_sentiment_score": "7.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAR", "relevance_score": "0.142961", "ticker_sentiment_score": "-0.001068", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000135", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBAI", "relevance_score": "0.095593", "ticker_sentiment_score": "-0.000226", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCEL", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000702", "ticker_sentiment_label": "Neutral"}, {"ticker": "METX", "relevance_score": "0.095593", "ticker_sentiment_score": "-0.002701", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAGS", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000385", "ticker_sentiment_label": "Neutral"}, {"ticker": "TROO", "relevance_score": "0.095593", "ticker_sentiment_score": "0.000825", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSDT", "relevance_score": "0.095593", "ticker_sentiment_score": "0.001418", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONN", "relevance_score": "0.142961", "ticker_sentiment_score": "0.000752", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:RUB", "relevance_score": "0.047883", "ticker_sentiment_score": "0.003185", "ticker_sentiment_label": "Neutral"}]}]}